
US FDA orders new eye risk warnings for Ozempic, Zepbound
来源:Reuters发布于 2026-11-09
The US FDA on Monday informed patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs used for weight loss and diabetes...
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。